Biocon Biologics, Yoshindo launch Ustekinumab biosimilar in Japan EP News Bureau May 21, 2025 Ustekinumab, a monoclonal antibody, is approved for the treatment of psoriasis vulgaris and psoriatic arthritis (PsA)
